A randomized, double-blind trial of parenteral low dose versus high dose interferon-β in combination with cryotherapy for treatment of condyloma acuminatum

Antiviral Research

Volumn 35, Issue 1, 1997, Pages 41-52

  Bonnez, William ^a   Oakes, David ^b   Bailey Farchione, Allyson ^a   Choi, Anna ^b   Hallahan, Dawn ^a   Corey, Lawrence ^c   Barnum, Gail ^c   Pappas, Peter G ^d   Halloway, Melissa ^d   Stoler, Mark H ^e,f   Reichman, Richard C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d University of Alabama at Birmingham   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Anogenital warts; Condyloma acuminatum; Cryotherapy; Human papillomavirus; Interferon beta; Randomized clinical trial

Indexed keywords

LIQUID NITROGEN; RECOMBINANT BETA INTERFERON;

ADULT; AEROSOL; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; MALAISE; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; VERRUCA VULGARIS; VOMITING;

ADULT; COMBINED MODALITY THERAPY; CONDYLOMATA ACUMINATA; CRYOTHERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-BETA; MALE; RECURRENCE;

HUMAN PAPILLOMAVIRUS; VERRUCA;

EID: 0030925161     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)01037-1     Document Type: Article

References (39)

1. Anon. (1993) Sexually transmitted diseases treatment guidelines. MMWR 42(RR-14), 1-101.
2. Baron, S., Tyring, S.K., Fleischmann, W.R. Jr., Coppenhaver, D.H., Niesel, D.W., Klimpel, G.R., Stanton, J. and Hughes, T.K. (1991) The interferons. Mechanisms of action and clinical applications. J. Am. Med. Assoc. 266, 1375-1383.
3. Becker, T.M., Stone, K.M. and Alexander, E.R. (1987) Genital human papillomavirus infection. A growing concern. Obstet. Gynecol. Clin. North Am. 14, 389-396.
4. Bonnez, W., Oakes, D., Bailey-Farchione, A., Choi, A., Hallahan, D., Pappas, P., Halloway, M., Corey, L., Barnum, G., Dunne, A., Stoler, M.H., Demeter, L.M. and Reichman, R.C. (1995) A randomized, double-blind, placebo-controlled trial of systemically administered alpha-, beta-, or gamma-interferon in combination with cryotherapy for the treatment of condyloma acuminatum. J. Infect. Dis. 171, 1081-1089.
5. Condylomata International Collaborative Study Group. (1991a) A comparison of interferon alfa-2a and podophyllin in the treatment of primary condylomata acuminata. Genitourin. Med. 67, 394-399.
6. Condylomata International Collaborative Study Group. (1991b) Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. J. Am. Med. Assoc. 265, 2684-2687.
7. Condylomata International Collaborative Study Group. (1993) Randomized placebo-controlled double-blind combined therapy with laser surgery and systemic interferon-alpha 2a in the treatment of anogenital condylomata acuminatum. J. Infect. Dis. 167, 824-829.
8. Cox, D.R. (1972) Regression models and life-tables. J. R. Stat. Soc. 34, 187-220.
9. Cox, D.R. and Oakes, D. (1984) Analysis of survival data, Chapman and Hall, London.
10. 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts. J. Infect. Dis. 162, 52-59.
11. Eron, L.J., Judson, F., Tucker, S., Prawer, S., Mills, J., Murphy, K., Hickey, M., Rogers, M., Flannigan, S., Hien, N., Katz, H.I., Goldman, S., Gottlieb, A., Adams, K., Burton, P., Tanner, D., Taylor, E. and Peets, E. (1986) Interferon therapy for condylomata acuminata. N. Engl. J. Med. 315, 1059-1064.
12. Fierlbeck, G., Breuninger, H., Fierlbeck, B. and Rassner, G. (1991) Condylomata acuminata - lokale und systemische Interferontherapie. Hautarzt 42, 39-43.
13. Friedman-Kien, A., Eron, L.J., Conant, M., Growdon, W., Badiak, H., Bradstreet, P.W., Fedorczyk, D., Trout, J.R. and Plasse, T.F. (1988) Natural interferon alfa for treatment of condylomata acuminata. J. Am. Med. Assoc. 259, 533-538.
14. Gall, S.A., Constantine, L. and Koukol, D. (1991) Therapy of persistent human papillomavirus disease with two different interferon species. Am. J. Obstet. Gynecol. 164, 130-134.
15. Gross, G., Ikenberg, H., Roussaki, A., Drees, N. and Schöpf, E. (1986) Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen. Chemotherapy 32, 537-541.
16. Gross, G., Degen, W., Hilgart, M., Kowalzick, L., Roussaki, A., Ruffi, T., Schöfer, H. and Brzoska, J. (1989) Recombinant interferon-gamma in genital warts: results of a multi-center placebo-controlled clinical trial. J. Interferon Res. 9 (Suppl. 2), S131.
17. Handley, J.M., Horner, T., Maw, R.D., Lawther, H. and Dinsmore, W.W. (1991) Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study. Genitourin. Med. 67, 297-302.
18. IFNB Multiple Sclerosis Study Group. (1993) Interferon beta-Ib is effective in relapsing-remitting multiple sclerosis. I Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 655-661.
19. Ikic, D., Bosnic, N., Smerdel, S., Jusic, D., Soos, E. and Delimar, N. (1975) Double blind clinical study with human leukocyte interferon in the therapy of condylomata acuminata. Proc. Symp. Clin. Use Interferon, pp. 229-233, Yugoslav Academic of Sciences and Arts, Zagreb.
20. Keay, S., Teng, N., Eisenberg, M., Story, B., Sellers, P.W. and Merigan, T.C. (1988) Topical interferon for treating condyloma acuminata in women. J. Infect. Dis. 158, 934-939.
21. Kling, A.R. (1992) Genital warts-Therapy. Sem. Dermatol. 11, 247-255.
22. Kurzrock, R., Rohde, M.F., Quesada, J.R., Gianturco, S.H., Bradley, W.A., Sherwin, S.A. and Gutterman, J.U. (1986) Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients. J. Exp. Med. 164, 1093-1101.
23. Ling, M.R. (1992) Therapy of genital human papillomavirus infection. Part II: Methods of treatment. Int. J. Dermatol. 31, 769-776.
24. Olsen, E.A., Lichtenstein, G.R. and Wilkinson, W.E. (1988) Changes in serum lipids in patients with condylomata acuminata treated with interferon alfa-n1 (Wellferon). J. Am. Acad. Dermatol. 19, 286-289.
25. Olsen, E.A., Kelly, F.F., Vollner, R.T., Buddin, D.A. and Week, P.K. (1989) Comparative study of systemic interferon alfa-n1 and isotretinoin in the treatment of resistant condylomata acuminata. J. Am. Acad. Dermatol. 20, 1023-1030.
26. Oriel, D. (1990) Genital human papillomavirus infection. In: K., Holmes, P.-A., Mardh, P.F., Sparling, P.J., Wiesner, W., Cates, Jr., S.M., Lemon and W.E., Stamm (Eds.), Sexually Transmitted Diseases (2nd edition), pp. 433-441, McGraw Hill, New York, NY.
27. Petersen, C.S., Bjerring, P., Larsen, J., Blaakær, J., Hagdrup, H., From, E. and Obergaard, L. (1991) Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study. Genitourin. Med. 67, 99-102.
28. Reichman, R.C., Micha, J.P., Weck, P.K., Bonnez, W., Wold, D., Whisnant, J.K., Mounts, P., Trofatter, K.F., Kucera, P. and Gall, S.A. (1988a) Interferon alfa-n1 (Wellferon) for refractory genital warts: efficacy and tolerance of low dose systemic therapy. Antiviral Res. 10, 41-57.
29. Reichman, R.C., Oakes, D., Bonnez, W., Greisberger, C., Tyring, S., Miller, L., Whitley, R., Carveth, H., Weidner, M., Krueger, G., Yorkey, L., Roberts, N.J., Jr. and Dolin, R. (1988b) Treatment of condyloma acuminatum with three different interferons administered intralesionally: A double-blind, placebo-controlled trial. Ann. Int. Med. 108, 675-679.
30. Reichman, R.C., Oakes, D., Bonnez, W., Brown, D., Mattison, H.R., Bailey-Farchione, A., Stoler, M.H., Demeter, L.M., Tyring, S.K., Miller, L., Whitley, R., Carveth, H., Weidner, M., Krueger, G. and Choi, A. (1990) Treatment of condyloma acuminatum with three different alpha interferon preparations administered parenterally: A double-blind, placebo-controlled trial. J. Infect. Dis. 162, 1270-1276.
31. Rosenzweig, I.B., Wiebe, D.A., Borden, E.C., Storer, B. and Shrago, E.S. (1987) Plasma lipoprotein changes in humans induced by β-interferon. Atherosclerosis 67, 261-267.
32. Schonfeld, A., Nitke, S., Schattner, A., Wallach, D., Crespi, M., Hahn, T., Levavi, H., Yarden, O., Shoham, J., Doerner, T. and Revel, M. (1984) Intramuscular human interferon-β injections in treatment of condylomata acuminata. Lancet i, 1038-1042.
33. Schulze, H.-J. and Mahrle, G. (1988) Recombinant interferon gamma in psoriasis. Arch. Dermatol. 124, 487-488.
34. Stone, K.M. (1989) Epidemiologie aspects of genital HPV infection. Clin. Obstet. Gynecol. 1989, 112-116.
35. Vadhan-Raj, S., Nathan, C.F., Sherwin, S.A., Oettgen, H.F. and Krown, S.E. (1986) Phase I trial of recombinant interferon gamma by 1 hour iv infusion. Cancer Treat. Rep. 70, 609-614.
36. Vance, J.C., Bart, B.J., Hansen, R.C., Reichman, R.C., McEwen, C., Hatch, K.D., Berman, B. and Tanner, D.J. (1986) Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol. 122, 272-277.
37. Vesterinen, E., Meyer, B., Cantell, K. and Purola, E. (1984a) Topical treatment of flat vaginal condyloma with human leukocyte interferon. Obstet. Gynecol. 64, 535-538.
38. Vesterinen, E., Meyer, B., Purola, E. and Cantell, K. (1984b) Treatment of vaginal flat condyloma with interferon cream. Lancet i, 157.
39. Zwiorek, I., Schmidt-Rhode, P. and Schulz, K.-D. (1989) Interferon in der Behandlung von Condylomata acuminata. Geburtsh. u. Frauenheilk. 49, 1001-1005.